{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:08:40Z","timestamp":1793372920568,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Pudong Health and Family Planning Commission of Shanghai","award":["PWZz2013-04"],"award-info":[{"award-number":["PWZz2013-04"]}]},{"name":"Clinical Research Program of the Chinese Medical Association","award":["12030510351"],"award-info":[{"award-number":["12030510351"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12902-017-0211-5","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T12:48:37Z","timestamp":1506343717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance"],"prefix":"10.1186","volume":"17","author":[{"given":"Xinfeng","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaosheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,25]]},"reference":[{"key":"211_CR1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","volume":"65","author":"AF Hofmann","year":"2008","unstructured":"Hofmann AF, Hagey LR. Bile acids:Chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci. 2008;65:2461\u201383.","journal-title":"Cell Mol Life Sci"},{"key":"211_CR2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","volume":"284","author":"DJ Parks","year":"1999","unstructured":"Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, et al. Bile acids: Natural ligands for an orphan nuclear receptor. Science. 1999;284:1365\u20138.","journal-title":"Science"},{"key":"211_CR3","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","volume":"48","author":"I Kim","year":"2007","unstructured":"Kim I, Ahn SH, Inagaki T, Choi M, Ito S, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 2007;48:2664\u201372.","journal-title":"Lipid Res"},{"key":"211_CR4","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00400.2012","volume":"304","author":"MJ Potthoff","year":"2013","unstructured":"Potthoff MJ, Potts A, He T, Duarte JA, Taussig R, et al. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am J Physiol Gastrointest Liver Physiol. 2013;304:G371\u201380.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"211_CR5","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","volume":"278","author":"Y Kawamata","year":"2003","unstructured":"Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003;278:9435\u201340.","journal-title":"J Biol Chem"},{"key":"211_CR6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2005.01.139","volume":"329","author":"S Katsuma","year":"2005","unstructured":"Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun. 2005;329:386\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"211_CR7","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87:1409\u201339.","journal-title":"Physiol Rev"},{"key":"211_CR8","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1210\/endo-123-4-2009","volume":"123","author":"C Orskov","year":"1988","unstructured":"Orskov C, Holst JJ, Nielsen OV. Effect of truncated glucagon-like peptide-1 [proglucagon-(78\u2013107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology. 1988;123:2009\u201313.","journal-title":"Endocrinology"},{"key":"211_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","volume":"10","author":"C Thomas","year":"2009","unstructured":"Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009;10:167\u201377.","journal-title":"Cell Metab"},{"key":"211_CR10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2014.05.016","volume":"737","author":"M Feigh","year":"2014","unstructured":"Feigh M, Hjuler ST, Andreassen KV, et al. Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats. Eur J Pharmacol. 2014;737:91\u20136.","journal-title":"Eur J Pharmacol"},{"key":"211_CR11","unstructured":"Zhou YS, G Y, Li B, Liu DG, Chi JM, et al. (2005) A rat model of type 2 diabetes mellitus induced by high fat chow and low dose streptozocin injection. Acta Laboratorium Animals Scientia Sinica 13: 154\u2013158."},{"key":"211_CR12","first-page":"138","volume":"11","author":"JL Yang","year":"2003","unstructured":"Yang JL, Li G, Liu YP, Zhang FL, Cui JL, et al. Establishing a rat model similar to the adult patient of the general type 2 diabetes by long-term fat-enriched fed and lower dose of streptozocin-treated rats. Acta Laboratorium Animals Scientia Sinica. 2003;11:138\u201341.","journal-title":"Acta Laboratorium Animals Scientia Sinica"},{"key":"211_CR13","doi-asserted-by":"crossref","unstructured":"Roberts RE, Glicksman C, Alaghband-Zadeh J,etc. (2011) The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin. Clin Endocrinol(Oxf) 74(1):67\u201372.","DOI":"10.1111\/j.1365-2265.2010.03886.x"},{"key":"211_CR14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ LiVak","year":"2001","unstructured":"LiVak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"211_CR15","first-page":"39422","volume":"278","author":"S Kovacic","year":"2003","unstructured":"Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, et al. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J BiolChem. 2003;278:39422\u20137.","journal-title":"J BiolChem"},{"key":"211_CR16","first-page":"281","volume":"7","author":"YL Wu","year":"2007","unstructured":"Wu YL, Zhao BZ, Xi GX, Gao CH. An experimental study of impaired glucose tolerance in Wistar rats. Chinese Remedies & Clinics. 2007;7:281\u20133.","journal-title":"Chinese Remedies & Clinics"},{"key":"211_CR17","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1074\/jbc.M010878200","volume":"276","author":"S Gupta","year":"2001","unstructured":"Gupta S, Stravitz RT, Dent P, Hylemon PB. Down-regulation of cholesterol 7a-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J Biol Chem. 2001;276:15816\u201322.","journal-title":"J Biol Chem"},{"key":"211_CR18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.2011.01561.x","volume":"165","author":"HE Parker","year":"2012","unstructured":"Parker HE, Wallis K, le Roux CW, Wong KY, Reimann F, et al. Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br JPharmacol. 2012;165:414\u201323.","journal-title":"Br JPharmacol"},{"key":"211_CR19","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1038\/ncomms8629","volume":"6","author":"MS Trabelsi","year":"2015","unstructured":"Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun. 2015;6:7629.","journal-title":"Nat Commun"},{"key":"211_CR20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/gut.34.9.1219","volume":"34","author":"TE Adrian","year":"1993","unstructured":"Adrian TE, Ballantyne GH, Longo WE, Bilchik AJ, Graham S, et al. Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut. 1993;34:1219\u201324.","journal-title":"Gut"},{"key":"211_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/thy.2007.0255","volume":"18","author":"C Thomas","year":"2008","unstructured":"Thomas C, Auwerx J, Schoonjans K. Thyroid economy \u2013 regulation, cell biology, thyroid hormone metabolism and action: the special edition:metabolic effects of thyroid hormones. Thyroid. 2008;18:167\u201374.","journal-title":"Thyroid"},{"key":"211_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstr\u00f6m A, Felin J, J\u00e4ntti S, Marschall HU, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism. 2013;17:225\u201335.","journal-title":"Cell Metabolism"},{"key":"211_CR23","unstructured":"Pars\u00e9us A, Sommer N, Sommer F, Caesar R, Molinaro A, et al.(2016) Microbiota-induced obesity requires farnesoid X receptor. Gut 0:1\u20139."}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-017-0211-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T12:48:55Z","timestamp":1506343735000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-017-0211-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,25]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["211"],"URL":"https:\/\/doi.org\/10.1186\/s12902-017-0211-5","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,25]]},"article-number":"60"}}